PS www.ProStocks.com
|
|
Incorporated in 2003, Infinium Pharmachem Limited manufactures & supplies Iodine Derivatives, APIs, and Iodination reaction-based bulk drugs.
The company offers R & D services and commercial scale manufacturing and packaging for Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals & other chemical industries.
Infinium Pharmachem's manufacturing plant is located in Gujarat - INDIA, which spans across 4100 Sq. Mtr. Plot area. The facility is FDA certified & GMP compliant with capabilities of producing complex Iodine Derivatives.
The company serves to over 15+ countries across the globe and has over 200+ Iodine Derivatives and 7+ APIs.
| IPO Date | Mar 31, 2023 to Apr 5, 2023 |
| Listing Date | Apr 17, 2023 |
| Face Value | ₹10 per share |
| Price | ₹135 per share |
| Lot Size | 1000 Shares |
| Total Issue Size | 1,875,000 shares (aggregating up to ₹25.26 Cr) |
| Fresh Issue | 1,875,000 shares (aggregating up to ₹25.26 Cr) |
| Employee Discount | Rs 13.5 per share |
| Issue Type | Fixed Price Issue IPO |
| Listing At | NSE SME |
| Market Maker portion | 94,000 shares (Swastika Investmart) |
| Other Shares Offered | 937,500 (50.00%) |
| Retail Shares Offered | 937,500 (50.00%) |
| Total Shares Offered | 1,875,000 |
Infinium Pharmachem IPO opens on Mar 31, 2023, and closes on Apr 5, 2023.
| Event | Tentative Date |
|---|---|
| Opening Date | Friday, 31 March 2023 |
| Closing Date | Wednesday, 5 April 2023 |
| Basis of Allotment | Tuesday, 11 April 2023 |
| Initiation of Refunds | Wednesday, 12 April 2023 |
| Credit of Shares to Demat | Thursday, 13 April 2023 |
| Listing Date | Monday, 17 April 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on Apr 5, 2023 |
The Infinium Pharmachem IPO lot size is 1000 shares.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1000 | ₹135,000 |
| Retail (Max) | 1 | 1000 | ₹135,000 |
| HNI (Min) | 2 | 2,000 | ₹270,000 |
| Lot Size Calculator | |||
Mr. Sanjaykumar Viththalbhai Patel, Mr. Pravin Bhadabhai Madhani, and Mr. Mitesh Lavjibhai Chikhaliya are the company promoters.
| Pre Issue Share Holding | 100% |
| Post Issue Share Holding | 73.05% |
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Total Borrowing |
|---|---|---|---|---|---|
| 31-Mar-20 | 2,244.60 | 3,941.64 | 93.40 | 424.74 | 566.17 |
| 31-Mar-21 | 3,418.27 | 7,115.37 | 272.48 | 702.32 | 579.47 |
| 31-Mar-22 | 5,899.95 | 10,005.25 | 610.64 | 1,310.22 | 1,385.01 |
| 30-Sep-22 | 7,075.71 | 7,985.39 | 551.01 | 1,855.77 | 1,614.71 |
| Amount in ₹ Lakhs | |||||
| KPI | Values |
|---|---|
| P/E (x) | 7.83 |
| Market Cap (₹ Cr.) | 93.93 |
The proceeds from the fresh issue will be utilized for the following objects:
1. Marketing and branding expenses (including registration in reach - Europe, and other marketing expenses).
2. Repayment of some of the existing loans and expansion of units.
3. To meet incremental working capital requirements.
4. To meet public issue expenses.
[Dilip Davda] IPL is in the pharma and healthcare segment and has posted growth in its top and bottom lines for the reported periods. Super earnings for FY23 H1 raise eyebrows and concern over the sustainability of such margins going forward. Well-informed investors may park funds for medium to long-term rewards. Read detail review...
The Infinium Pharmachem IPO is subscribed 1.84 times on Apr 5, 2023 7:30:00 PM. The public issue subscribed 1.86 times in the retail category, times in the QIB category, and 1.80 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| Other | 1.80 |
| Retail | 1.86 |
| Total | 1.84 |
Total Application : 1,742 (1.86 times)
| Listing Date | Apr 17, 2023 |
| BSE Script Code | |
| NSE Symbol | INFINIUM |
| ISIN | INE0MRE01011 |
| Final Issue Price | ₹135 per share |
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| NSE SME |
|---|
| ₹135.00 |
| ₹141.50 |
| ₹141.50 |
| ₹148.55 |
| ₹147.80 |
Infinium Pharmachem Limited
38 G.I.D.C Sojitra,
Taluka - Sojitra,
Dist. - Anand - 387240
Phone: +91-2692-238849
Email: info@infiniumpharmachem.com
Website: https://infiniumpharmachem.com/
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://www.bigshareonline.com/
SME Company Owners
We could help you get listed on the stock market.
Check our SME IPO Guide 
Infinium Pharmachem IPO is a SME IPO of 1,875,000 equity shares of the face value of ₹10 aggregating up to ₹25.26 Crores. The issue is priced at ₹135 per share. The minimum order quantity is 1000 Shares.
The IPO opens on Mar 31, 2023, and closes on Apr 5, 2023.
Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Infinium Pharmachem IPO using UPI as a payment gateway. Zerodha customers can apply in Infinium Pharmachem IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Infinium Pharmachem IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Infinium Pharmachem IPO opens on Mar 31, 2023 and closes on Apr 5, 2023.
Infinium Pharmachem IPO lot size is 1000 Shares and the minimum order quantity is .
You can apply in Infinium Pharmachem IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Infinium Pharmachem IPO will be done on Tuesday, 11 April 2023, and the allotted shares will be credited to your demat account by Thursday, 13 April 2023. Check the Infinium Pharmachem IPO allotment status.
Useful Articles
FREE Account Opening (₹0)
FREE Intraday Trading (Eq, F&O)
30 days brokerage free trading
Free - Relationship Manager
Free - Classroom Training
|
|
RHP
IPO Mentor (500+ Posts, 300+ Likes)
Top Contributor (300+ Posts, 100+ Likes)
IPO Guru (3900+ Posts, 4400+ Likes)
Late but not wrong